Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)

[1]  B. O'driscoll,et al.  A long-term prospective assessment of home nebulizer treatment. , 1992, Respiratory medicine.

[2]  W. McNicholas,et al.  Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[3]  T. Bengtsson,et al.  Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study , 2002, European Respiratory Journal.

[4]  B. Celli,et al.  Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[5]  P. Leuenberger,et al.  Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. , 2000, Clinical therapeutics.

[6]  B. Lipworth,et al.  Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. , 1996, Thorax.

[7]  J. Wlodarczyk,et al.  Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital. , 1998, Journal of quality in clinical practice.

[8]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[9]  P. Buckley,et al.  The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. , 1990, The American review of respiratory disease.

[10]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[11]  B. Winkelmann,et al.  Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease. , 1994, Chest.

[12]  D. Brooks,et al.  Nutritional supplementation for stable chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[13]  S. M. Lee,et al.  The effects of pulmonary rehabilitation in the national emphysema treatment trial. , 2005, Chest.

[14]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[15]  G. Donaldson,et al.  Epidemiological relationships between the common cold and exacerbation frequency in COPD , 2005, European Respiratory Journal.

[16]  D. Zamir,et al.  Inhaled budesonide therapy for patients with stable COPD. , 1995, Chest.

[17]  N. Ambrosino,et al.  Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.

[18]  J. Barberà,et al.  Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[19]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[20]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[21]  F. Abroug,et al.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial , 2001, The Lancet.

[22]  S. Spiro,et al.  The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. , 1988, The American review of respiratory disease.

[23]  H. Worth,et al.  COPD und Psyche - ein Überblick , 2005 .

[24]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[25]  H. Magnussen,et al.  Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. , 1993, Chest.

[26]  P. Poole,et al.  The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[27]  John Connett,et al.  The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.

[28]  M. Prato,et al.  Noninvasive Mechanical Ventilation in the Weaning of Patients with Respiratory Failure Due to Chronic Obstructive Pulmonary Disease , 1998, Annals of Internal Medicine.

[29]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[30]  D. Dusser,et al.  The effect of tiotropium on exacerbations and airflow in patients with COPD , 2006, European Respiratory Journal.

[31]  P De Vuyst,et al.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema. , 1995, American journal of respiratory and critical care medicine.

[32]  A. Simonds,et al.  Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. , 1995, Thorax.

[33]  R. Dittus,et al.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.

[34]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[35]  N. Seersholm,et al.  Clinical features and prognosis of life time non-smokers with severe α1-antitrypsin deficiency , 1998, Thorax.

[36]  F. Maltais,et al.  Aerobic and strength training in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[37]  J. Best,et al.  Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. , 1991, The European respiratory journal.

[38]  M. Decramer,et al.  Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.

[39]  A. Agustí,et al.  Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. , 1996, The European respiratory journal.

[40]  D. Barker,et al.  Relation of fetal growth to adult lung function in south India. , 1997, Thorax.

[41]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[42]  A. Woodcock,et al.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.

[43]  D. Niewoehner,et al.  Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.

[44]  C. Rand,et al.  Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years. , 2002, Preventive medicine.

[45]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[46]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[47]  K. Rabe,et al.  Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. , 2005, Respiratory medicine.

[48]  P. Plant,et al.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.

[49]  J. Earis,et al.  Acute bronchodilator trials in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[50]  D. Taylor,et al.  The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. , 1985, The American review of respiratory disease.

[51]  G. Zeng,et al.  Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. , 2004, Chinese medical journal.

[52]  W. Morgan,et al.  Maternal smoking and infant lung function. Further evidence for an in utero effect. , 1998, American journal of respiratory and critical care medicine.

[53]  J. van der Palen,et al.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.

[54]  J. Cooper,et al.  Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.

[55]  Catherine Pettinari,et al.  The last year of life of COPD: a qualitative study of symptoms and services. , 2004, Respiratory medicine.

[56]  K. Kenn,et al.  Effektivität der pneumologischen Anschluss-Rehabilitation (AHB) , 2006 .

[57]  D. Georgopoulos.  Symptoms and signs of COPD , 1991 .

[58]  R. Novick,et al.  Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[59]  Thierry Troosters,et al.  Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic review , 2005, Respiratory research.

[60]  J. V. van Noord,et al.  Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. , 2006, Chest.

[61]  R. Buhl,et al.  Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. , 1998, The European respiratory journal.

[62]  N. Pride,et al.  In defence of the carbon monoxide transfer coefficient Kco (TL/VA). , 2001, The European respiratory journal.

[63]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[64]  P. Jones,et al.  Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.

[65]  J. Williams,et al.  Pneumococcal vaccine and patients with chronic lung disease. , 1986, Annals of internal medicine.

[66]  P. Calverley,et al.  Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 2005, Thorax.

[67]  J. Wilson,et al.  Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. , 1999, Chest.

[68]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[69]  N. Hill,et al.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.

[70]  M. Polkey,et al.  Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD , 2004, Thorax.

[71]  W. Knaus,et al.  Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .

[72]  Marshall I Hertz,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[73]  E. Daviskas,et al.  Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.

[74]  T. Todisco,et al.  Mild prematurity and respiratory functions , 2005, European Journal of Pediatrics.

[75]  D. O’Donnell,et al.  Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[76]  A Rossi,et al.  Respiratory mechanics in mechanically ventilated patients with respiratory failure. , 1985, Journal of applied physiology.

[77]  J. Vestbo,et al.  Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. , 1999, Respiratory medicine.

[78]  M. Aubier,et al.  A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.

[79]  A. Connors,et al.  Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. , 1989, Annals of emergency medicine.

[80]  Richard Casaburi,et al.  Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease , 2000 .

[81]  C Lovato,et al.  Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. , 2011, The Cochrane database of systematic reviews.

[82]  H. Kreisman,et al.  The relationship between pulmonary function and dyspnea in obstructive lung disease. , 1989, Chest.

[83]  H. Magnussen,et al.  Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[84]  W. Vollmer,et al.  Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[85]  R. Zuwallack,et al.  Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. , 2003, Chest.

[86]  A. Connors,et al.  Theophylline concentrations in patients with acute exacerbation of COPD. , 1990, The American journal of emergency medicine.

[87]  T. Lukens,et al.  Physician estimation of FEV1 in acute exacerbation of COPD. , 1994, Chest.

[88]  H. Worth,et al.  Kombination von Asthma und COPD - häufiger als man denkt? , 2006 .

[89]  T. Lukens,et al.  Spirometric criteria for hospital admission of patients with acute exacerbation of COPD. , 1991, Chest.

[90]  S. Weingarten,et al.  Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. , 1997, Chest.

[91]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[92]  A. Gulsvik,et al.  Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. , 1998, The European respiratory journal.

[93]  B. Fleury,et al.  The cost of treating COPD patients with long-term oxygen therapy in a French population. , 1996, Chest.

[94]  M. Ikäheimo,et al.  Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy. , 1988, Chest.

[95]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[96]  P. Lange,et al.  Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient! , 2000, Respiratory medicine.

[97]  Marshall I Hertz,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[98]  E. Weitzenblum,et al.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[99]  D. Köhler,et al.  Eine “Epidemiologie” zum Stellenwert von oral appliziertem Morphium als Therapieform des schwergradigen Lungenemphysems vom Pink-Puffer-Typ , 2001, Medizinische Klinik.

[100]  J. Erikssen,et al.  Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? , 2006, Chest.

[101]  iorgio,et al.  NONINVASIVE VENTILATION FOR ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2000 .

[102]  F. Venuta,et al.  Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. , 2006, Chest.

[103]  M. Fiore,et al.  The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. , 1994, JAMA.

[104]  M. Pathy,et al.  Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. , 1981, Thorax.

[105]  D. Brooks,et al.  Nutritional supplementation for stable chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[106]  S. Rennard.  Extended bronchodilator treatment in chronic obstructive pulmonary disease , 1996 .

[107]  M. Polkey,et al.  Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study , 2004, BMJ : British Medical Journal.

[108]  D. Postma,et al.  Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial , 2005, Thorax.

[109]  G. Dickinson,et al.  Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy. , 1990, Chest.

[110]  J. Ansquer,et al.  Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease. , 1991, The European respiratory journal.

[111]  C. Vogelmeier,et al.  Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[112]  J. Lellouch,et al.  Twelve years spirometric changes among Paris area workers. , 1979, International journal of epidemiology.

[113]  Gordon H Guyatt,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.

[114]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[115]  T. Evald,et al.  Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. , 1994, Respiratory medicine.

[116]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[117]  H. Worth,et al.  Does patient education modify behaviour in the management of COPD? , 2004, Patient education and counseling.

[118]  P. Weiner,et al.  The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. , 2000, Chest.

[119]  D. Postma,et al.  Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. , 1994, The European respiratory journal.

[120]  J. Stoller,et al.  Inpatient management of chronic obstructive pulmonary disease. , 1998, Respiratory care clinics of North America.

[121]  P. Young,et al.  Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. , 1999, The European respiratory journal.

[122]  P. Ward,et al.  Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population , 2001, Journal of the American Geriatrics Society.

[123]  W M Thurlbeck,et al.  Radiographic appearance of the chest in emphysema. , 1978, AJR. American journal of roentgenology.

[124]  F. Maltais,et al.  Self-management reduces both short- and long-term hospitalisation in COPD , 2005, European Respiratory Journal.

[125]  J. Higgins,et al.  A systematic review of the use of opioids in the management of dyspnoea , 2002, Thorax.

[126]  L. Forkert,et al.  Evaluation of bronchodilator responses in patients with “irreversible” emphysema , 2001, European Respiratory Journal.

[127]  J. V. van Noord,et al.  Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD , 2005, European Respiratory Journal.

[128]  E. Wouters,et al.  A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. , 2003, Chest.

[129]  M. Decramer,et al.  Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial , 2002, European Respiratory Journal.

[130]  A. Cutillo,et al.  Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[131]  D. O’Donnell,et al.  Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[132]  M. Decramer,et al.  Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.

[133]  J. Britton,et al.  Helping people to stop smoking: the new smoking cessation guidelines , 1999, Thorax.

[134]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[135]  C. Aranda,et al.  Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. , 1987, Chest.

[136]  R. Zuwallack,et al.  Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease , 2001 .

[137]  R. Pistelli,et al.  Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[138]  J. Wedzicha,et al.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.

[139]  M. Cazzola,et al.  Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. , 1998, Chest.

[140]  B. Celli,et al.  Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[141]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[142]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[143]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[144]  M. Niederman,et al.  Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. , 2002, Archives of internal medicine.

[145]  P. Ward,et al.  Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. , 2004, The Journal of infectious diseases.

[146]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[147]  C. Laurell,et al.  The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .

[148]  Stanton A Glantz,et al.  Effect of smoke-free workplaces on smoking behaviour: systematic review , 2002, BMJ : British Medical Journal.

[149]  E. Wouters,et al.  Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[150]  R. Berger,et al.  Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction. , 1988, The American review of respiratory disease.

[151]  G. Parr,et al.  Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis. , 1987, British journal of diseases of the chest.

[152]  N. Eiser,et al.  Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.

[153]  Hunter Am,et al.  The nutritional status of patients with chronic obstructive pulmonary disease. , 1981 .

[154]  R. Casaburi,et al.  Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. , 2005, Chest.

[155]  D. Niewoehner,et al.  Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. , 1987, Annals of internal medicine.

[156]  U. Cegla,et al.  [Physical therapy in patients with COPD and tracheobronchial instability--comparison of 2 oscillating PEP systems (RC-Cornet, VRP1 Desitin). Results of a randommized prospective study of 90 patients]. , 1997, Pneumologie.

[157]  L. Sharples,et al.  Assessment of survival benefit after lung transplantation by patient diagnosis. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[158]  B. Burrows.  The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago "COPD" series. , 1989, The American review of respiratory disease.

[159]  G. Boman,et al.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.

[160]  D. A. Bradley,et al.  Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia. , 1978, The New England journal of medicine.

[161]  Charles B. Fooe.  Physician estimation of FEV1 in acute exacerbation of COPD: Emerman CL, Lukens TW, Effron D Chest 105:1709–1712 Jun 1994 , 1994 .

[162]  L Battolla,et al.  Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[163]  P. Young,et al.  Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. , 1999, Australian and New Zealand journal of medicine.

[164]  J. Garcia-Aymerich,et al.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study , 2003, Thorax.

[165]  J. B. Rasmussen,et al.  Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. , 1988, The European respiratory journal.

[166]  B. Make,et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.

[167]  A. Verbeek,et al.  Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. , 1991, BMJ.

[168]  N. Adair,et al.  Exercise rehabilitation and chronic obstructive pulmonary disease stage. , 1999, American journal of respiratory and critical care medicine.

[169]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[170]  H. D. Short,et al.  Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. , 1987, The American review of respiratory disease.

[171]  Miriam J. Johnson,et al.  Erratum to the “The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine”: [Respiratory Medicine 98(1) 66–77] , 2004 .

[172]  F. Martinez,et al.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 2006 .

[173]  S. Chinn,et al.  Portable liquid oxygen and exercise ability in severe respiratory disability. , 1992, Thorax.

[174]  J. Deslauriers,et al.  Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.

[175]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[176]  Elizabeth M. Borycki,et al.  Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention , 2003 .

[177]  H. Worth,et al.  Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung , 2001 .

[178]  Michael A. Kuskowski,et al.  Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. , 2000, American journal of respiratory and critical care medicine.

[179]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[180]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[181]  Alan D. Lopez,et al.  The global burden of disease, 1990–2020 , 1998, Nature Medicine.

[182]  R. Negro,et al.  Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline , 2003 .

[183]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[184]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[185]  D. Denison,et al.  Value of computed tomography for selecting patients with bullous lung disease for surgery. , 1986, Thorax.

[186]  D. Sin,et al.  Bmc Pulmonary Medicine Effects of Inhaled Corticosteroids on Sputum Cell Counts in Stable Chronic Obstructive Pulmonary Disease: a Systematic Review and a Meta-analysis , 2022 .

[187]  J. Muir,et al.  Selection criteria and programmes for pulmonary rehabilitation in COPD patients. Rehabilitation and Chronic Care Scientific Group of the European Respiratory Society. , 1997, The European respiratory journal.

[188]  N. Hanania,et al.  The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD , 2003 .

[189]  M. Aubier,et al.  Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.

[190]  A. Thomson,et al.  Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. , 1993, Thorax.

[191]  J. Barnes,et al.  Efficacy and Tolerability of Oral Acetylcysteine (Fabrol®) in Chronic Bronchitis: A Double-Blind Placebo Controlled Study , 1984, The Journal of international medical research.

[192]  E F M Wouters,et al.  Effects of physical activity in mild to moderate COPD: a systematic review. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[193]  J. Karpel,et al.  A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. , 1990, Chest.

[194]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[195]  J. Schwartz,et al.  Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. , 1997, The European respiratory journal.

[196]  D. Mccrory,et al.  Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.

[197]  K. Chon,et al.  Ventilatory load characteristics during ventilatory muscle training. , 1994, American journal of respiratory and critical care medicine.

[198]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[199]  J. Montserrat,et al.  Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. , 1988, The European respiratory journal.

[200]  R. Casaburi,et al.  Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[201]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[202]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[203]  G. Bonsignore,et al.  Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. , 1987, Respiration; international review of thoracic diseases.

[204]  Dennis Nowak,et al.  Krankheitskosten von COPD in Deutschland , 2004 .

[205]  R N Battista,et al.  Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. , 1988, JAMA.

[206]  C. Sanguinetti,et al.  N-Acetylcysteine Reduces the Exacerbation Rate in Patients with Moderate to Severe COPD , 1999, Respiration.

[207]  D Behera,et al.  Respiratory symptoms in Indian women using domestic cooking fuels. , 1991, Chest.

[208]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[209]  M. Wakefield,et al.  “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice , 1990, The Medical journal of Australia.

[210]  C. Ulrik.  Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. , 1995, Thorax.

[211]  Holger J. Schünemann,et al.  How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction , 2005, Thorax.

[212]  R. Phillips,et al.  A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.

[213]  C. Westermann,et al.  Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[214]  C. Cooper,et al.  Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease. , 1987, Bulletin europeen de physiopathologie respiratoire.

[215]  R. Rogers,et al.  Nutritional assessment and support in chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[216]  J. Macmahon,et al.  Cost minimisation analysis of provision of oxygen at home: are the Drug Tariff guidelines cost effective? , 1999, BMJ.

[217]  R. Zuwallack,et al.  Body composition and health-related quality of life in patients with obstructive airways disease. , 1997, The European respiratory journal.

[218]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[219]  J. Steier,et al.  Physikalische Therapie bei COPD - Evidence Based Medicine? , 2002 .

[220]  D. Mannino,et al.  Worldwide epidemiology of chronic obstructive pulmonary disease. , 1999, Current opinion in pulmonary medicine.

[221]  I. Cowan.  Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: Tashkin DP, Ashutosh K, Bleecker ER, et al Am J Med 81 (suppl 5A):81–90 Nov 1986 , 1987 .

[222]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[223]  R. Pauwels,et al.  Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. , 2002, Respiratory medicine.

[224]  M. De Salvo,et al.  In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. , 2001, Chest.

[225]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[226]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[227]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[228]  V. Brusasco,et al.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.

[229]  D. Nowak,et al.  Epidemiology and Health Economics of COPD Across Europe , 2005, Treatments in respiratory medicine.

[230]  R. Dahl,et al.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[231]  C. Marquette,et al.  Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors , 2006, Annals of Internal Medicine.

[232]  J. Macfarlane,et al.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community , 1993, The Lancet.

[233]  R. Pistelli,et al.  Correlates of osteoporosis in chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[234]  D. Sachs,et al.  Individualizing medical treatment for tobacco dependence. , 1996, The European respiratory journal.

[235]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[236]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[237]  D. Niewoehner,et al.  Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. , 1987, British journal of diseases of the chest.

[238]  J. Fitting.  Nutritional support in chronic obstructive lung disease. , 1992, Thorax.

[239]  W. Bailey,et al.  Smoking cessation: Information for specialists , 1996 .

[240]  E. Wouters,et al.  Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. , 2001, The European respiratory journal.

[241]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[242]  D. Hosmer,et al.  Increasing the efficacy of physician-delivered smoking interventions , 2007, Journal of General Internal Medicine.

[243]  J. Costantino,et al.  Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. , 1992, The American review of respiratory disease.

[244]  F. Maltais,et al.  Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. , 2005, Chest.

[245]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[246]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.